SubHero Banner
Text

Yupelri (revefenacin) – New drug approval

November 9, 2018 - Theravance Biopharma and Mylan announced the FDA approval Yupelri (revefenacin), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Download PDF